Rockaway, N.J. — October 3, 2025 — Leads & Copy — electroCore, Inc. (NASDAQ: ECOR) has announced the appointment of Jennifer Hayes as Vice President, Human Resources and Employee Success, effective October 6, 2025. The Compensation Committee of electroCore’s Board of Directors has granted Ms. Hayes 10,000 restricted stock units (RSUs) in connection with her employment. These RSUs were granted as an inducement material pursuant to NASDAQ Listing Rule 5635(c)(4). One-third of the RSUs will vest on each of the first, second, and third anniversaries of the grant date, contingent upon Ms. Hayes’ continued employment. Upon vesting, the RSUs will be settled in shares of the company’s common stock.
electroCore, Inc. is a commercial stage bioelectronic technology company focused on improving health and quality of life through innovative non-invasive bioelectronic technologies. Their leading prescription products, gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. The company also commercializes handheld Truvaga and TAC-STIM nVNS products for general wellness and human performance.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
